Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating polyneuropathy
It is the only FDA-approved intravenous immunoglobulin with two maintenance dosing options for CIDP
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.